{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:39:07Z","timestamp":1791189547324,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fitoterapia"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.fitote.2014.07.002","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T10:31:01Z","timestamp":1404988261000},"page":"36-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"special_numbering":"C","title":["The value of nature's natural product library for the discovery of New Chemical Entities: The discovery of ingenol mebutate"],"prefix":"10.1016","volume":"98","author":[{"given":"Steven M.","family":"Ogbourne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.fitote.2014.07.002_bb0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0167-7799(02)02080-2","article-title":"Plants and human health in the twenty-first century","volume":"20","author":"Raskin","year":"2002","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0010","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cbpa.2008.03.016","article-title":"The impact of natural products upon modern drug discovery","volume":"12","author":"Ganesan","year":"2008","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0015","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.drudis.2008.07.004","article-title":"Natural products in drug discovery","volume":"13","author":"Harvey","year":"2008","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.fitote.2014.07.002_bb0020","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1021\/ja909118a","article-title":"Natural products version 2.0: connecting genes to molecules","volume":"132","author":"Walsh","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.fitote.2014.07.002_bb0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1021\/np100550t","article-title":"Modern natural products drug discovery and its relevance to biodiversity conservation","volume":"74","author":"Kingston","year":"2011","journal-title":"J Nat Prod"},{"key":"10.1016\/j.fitote.2014.07.002_bb0030","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.bbagen.2013.02.008","article-title":"Natural products: a continuing source of novel drug leads","volume":"1830","author":"Cragg","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"48","key":"10.1016\/j.fitote.2014.07.002_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1021\/cen-v080n048.p039","article-title":"Pharmaceutical review","volume":"80","author":"Class","year":"2002","journal-title":"Chem Eng News"},{"issue":"26","key":"10.1016\/j.fitote.2014.07.002_bb0040","first-page":"159","article-title":"Rediscovering natural products as a source of new drugs","volume":"5","author":"Koehn","year":"2005","journal-title":"Discov Med"},{"key":"10.1016\/j.fitote.2014.07.002_bb0045","first-page":"205","article-title":"Natural products drug discovery","volume":"vol. 3","author":"Appendino","year":"2010"},{"key":"10.1016\/j.fitote.2014.07.002_bb0050","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/ci0200467","article-title":"Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry","volume":"43","author":"Feher","year":"2003","journal-title":"Chem Inf Comput Sci"},{"key":"10.1016\/j.fitote.2014.07.002_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/andp.18170550104","article-title":"Ueber das Morphium, eine neue salzf\u00e4hige Grundlage, und dieMekons\u00e4ure, als Hauptbestandtheile des Opiums","volume":"55","author":"Sertuerner","year":"1805","journal-title":"Ann. Phys."},{"key":"10.1016\/j.fitote.2014.07.002_bb0060","first-page":"753","article-title":"Camptothecin and taxol: discovery to clinical\u2014Thirteenth Bruce F. Cain Memorial Award Lecture","volume":"55","author":"Wall","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.fitote.2014.07.002_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1098-1128(199809)18:5<315::AID-MED3>3.0.CO;2-W","article-title":"Paclitaxel (Taxol): a success story with valuable lessons for natural product drug discovery and development","volume":"18","author":"Cragg","year":"1998","journal-title":"Med Res Rev"},{"key":"10.1016\/j.fitote.2014.07.002_bb0070","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2125.2006.02673.x","article-title":"Reflections on the \u2018discovery\u2019 of the antimalarial qinghao","volume":"61","author":"Hsu","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1289\/ehp.01109s169","article-title":"The value of plants used in traditional medicine for drug discovery","volume":"109","author":"Fabricant","year":"2001","journal-title":"Environ Health Perspect"},{"issue":"5","key":"10.1016\/j.fitote.2014.07.002_bb0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2003.08.003","article-title":"Why is big Pharma getting out of antibacterial drug discovery?","volume":"6","author":"Projan","year":"2003","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrd1657","article-title":"The evolving role of natural products in drug discovery","volume":"4","author":"Koehn","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.fitote.2014.07.002_bb0090","first-page":"507","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat Rev"},{"key":"10.1016\/j.fitote.2014.07.002_bb0095","first-page":"979","article-title":"Plant folklore: a tool for predicting sources of anti-tumor activity","volume":"60","author":"Spjut","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.fitote.2014.07.002_bb0100","series-title":"Biology of Gila monsters and beaded lizards","author":"Beck","year":"2005"},{"key":"10.1016\/j.fitote.2014.07.002_bb0105","doi-asserted-by":"crossref","first-page":"7402","DOI":"10.1016\/S0021-9258(18)42531-8","article-title":"Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas","volume":"15","author":"Eng","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.fitote.2014.07.002_bb0110","series-title":"Insulinotropic gut hormone glucagon-like peptide 1","first-page":"219","article-title":"Lessons from human studies with glucagon-like peptide-1: potential of the gut hormone for clinical use","author":"Byrne","year":"1997"},{"key":"10.1016\/j.fitote.2014.07.002_bb0115","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1007\/s00125-006-0433-y","article-title":"Exendin 4 controls insulin production in rat islet beta cells predominantly by potentiation of glucose-stimulated proinsulin biosynthesis at the translational level","volume":"49","author":"Alarcon","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.fitote.2014.07.002_bb0120","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/BF01316798","article-title":"Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man","volume":"38","author":"Wettergren","year":"1993","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.fitote.2014.07.002_bb0125","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2337\/db07-1214","article-title":"Exendin-4 protects b-cells from interleukin-1b-induced apoptosis by interfering with the c-Jun NH2-terminal kinase pathway","volume":"57","author":"Ferdaoussi","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.fitote.2014.07.002_bb0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1055\/s-0028-1105911","article-title":"Antiapoptotic action of exendin-4 in INS-1 beta cells: comparative protein pattern analysis of isolated mitochondria","volume":"41","author":"Tews","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.fitote.2014.07.002_bb0135","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.2337\/db09-0685","article-title":"Glucagon-like peptide-1 agonists protectpancreaticb-cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB","volume":"58","author":"Cunha","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.fitote.2014.07.002_bb0140","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1053\/j.gastro.2009.09.004","article-title":"Differential importance of glucose-dependent insulinotropic polypeptide vs glucagon-like peptide 1 receptor signaling for b-cell survival in mice","volume":"137","author":"Maida","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fitote.2014.07.002_bb0145","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1210\/en.2009-1166","article-title":"Exendin-4 prevents c-Jun N-terminal protein kinase activation by tumor necrosis factor-a (TNFa) and inhibits TNFa-induced apoptosis in insulin-secreting cells","volume":"151","author":"Natalicchio","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fitote.2014.07.002_bb0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-0030-1249035","article-title":"Exendin-4 protects pancreatic beta cells from the cytotoxic effect of rapamycin by inhibiting JNK and p38 phosphorylation","volume":"42","author":"Kawasaki","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.fitote.2014.07.002_bb0155","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1210\/en.2009-1113","article-title":"Decrease in b-cell proliferation precedes apoptosis during diabetes development in bio-breeding\/worcester rat: beneficial role of exendin-4","volume":"151","author":"P\u00e9rez-Arana","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.fitote.2014.07.002_bb0160","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1463-1326.2010.01238.x","article-title":"Exendin-4 protects pancreatic beta cells from human islet amyloid polypeptide-induced cell damage: potential involvement of AKT and mitochondria biogenesis","volume":"12","author":"Fan","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.fitote.2014.07.002_bb0165","doi-asserted-by":"crossref","first-page":"e9582","DOI":"10.1371\/journal.pone.0009582","article-title":"Artemisinin directly targets malarial mitochondria through its specific mitochondrial activation","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.fitote.2014.07.002_bb0170","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.2337\/db07-1541","article-title":"Exendin-4 stimulation of cyclin A2 in b-cell proliferation","volume":"57","author":"Song","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.fitote.2014.07.002_bb0175","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3727\/096368908786092766","article-title":"Exendin-4 treatment expands graft beta-cell mass in diabetic mice transplanted with a marginal number of fresh islets","volume":"17","author":"Juang","year":"2008","journal-title":"Cell Transplant"},{"key":"10.1016\/j.fitote.2014.07.002_bb0180","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1254\/jphs.09178FP","article-title":"Exendin-4 potentiates insulinotropic action partly via increasing b-cell proliferation and neogenesis and decreasing apoptosis in association with the attenuation of endoplasmic reticulum stress in islets of diabetic rats","volume":"111","author":"Kwon","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.fitote.2014.07.002_bb0185","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.2337\/db08-1651","article-title":"Age-dependent decline in b-cell proliferation restricts the capacity of beta-cell regeneration in mice","volume":"58","author":"Tschen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.fitote.2014.07.002_bb0190","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jdiacomp.2008.12.004","article-title":"Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area","volume":"24","author":"Xue","year":"2010","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.fitote.2014.07.002_bb0195","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/diacare.19.6.580","article-title":"Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients","volume":"19","author":"Creutzfeldt","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fitote.2014.07.002_bb0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(03)01692-3","article-title":"Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas","volume":"469","author":"Silvestre","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.fitote.2014.07.002_bb0205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1517\/17460441.2013.741580","article-title":"Discovery and development of exenatide: the first antidiabetic agent to leverage the multiple benefits of the incretin hormone, GLP-1","volume":"8","author":"Parkes","year":"2013","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.fitote.2014.07.002_bb0210","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.toxicon.2010.12.016","article-title":"The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent","volume":"59","author":"Furman","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.fitote.2014.07.002_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1331\/154434506775268698","article-title":"Exenatide: from the Gila monster to the pharmacy","volume":"46","author":"Triplitt","year":"2003","journal-title":"Am Pharm Assoc"},{"key":"10.1016\/j.fitote.2014.07.002_bb0220","doi-asserted-by":"crossref","first-page":"928","DOI":"10.5694\/j.1326-5377.1976.tb141173.x","article-title":"Home treatment of basal cell carcinoma","volume":"1","author":"Weedon","year":"1976","journal-title":"Med J Aust"},{"key":"10.1016\/j.fitote.2014.07.002_bb0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1440-0960.1988.tb00383.x","article-title":"Home treatment of skin cancer and solar keratoses","volume":"29","author":"Green","year":"1988","journal-title":"Aust J Dermatol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0230","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1158\/0008-5472.CAN-03-2837","article-title":"Antitumour activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death","volume":"64","author":"Ogbourne","year":"2004","journal-title":"Can Res"},{"key":"10.1016\/j.fitote.2014.07.002_bb0235","doi-asserted-by":"crossref","first-page":"8123","DOI":"10.4049\/jimmunol.177.11.8123","article-title":"Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate","volume":"177","author":"Challacombe","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0240","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1002\/ejoc.201200733","article-title":"Diterpenes from European Euphorbia species serving as prototypes for natural-product-based drug discovery","volume":"2012","author":"Vasas","year":"2012","journal-title":"Eur J Org Chem"},{"key":"10.1016\/j.fitote.2014.07.002_bb0245","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1095-8339.1987.tb01036.x","article-title":"The saga of the spurges: a review of classification and relationships in the Euphorbiales","volume":"94","author":"Webster","year":"1987","journal-title":"Bot J Linn Soc"},{"key":"10.1016\/j.fitote.2014.07.002_bb0250","first-page":"131","article-title":"Weeds of New South Wales","volume":"28","author":"Maiden","year":"1917","journal-title":"Ag Gazette NSW"},{"key":"10.1016\/j.fitote.2014.07.002_bb0255","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archopht.118.1.13","article-title":"The spectrum of ocular inflammation caused by Euphorbia plant sap","volume":"118","author":"Eke","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0260","unstructured":"Aylward JH. 1999. Anti-Cancer Compounds. International Patent PCT\/AU1998\/000656."},{"key":"10.1016\/j.fitote.2014.07.002_bb0265","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","article-title":"New colorimetric cytotoxicity assay for anticancer-drug screening","volume":"82","author":"Skehan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.fitote.2014.07.002_bb0270","first-page":"633","article-title":"The sap from Euphorbia peplus is effective against human nonmelanoma skin cancers","volume":"164","author":"Ramsay","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0275","unstructured":"Aylward JH. 2001. Therapeutic agents\u2014I. International patent PCT\/AU2001\/000679."},{"issue":"3","key":"10.1016\/j.fitote.2014.07.002_bb0280","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2010.12.038","article-title":"Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response","volume":"66","author":"Rosen","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0285","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/CAD.0b013e3280149ec5","article-title":"Proceedings of the First International Conference on PEP005","volume":"18","author":"Ogbourne","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"10","key":"10.1016\/j.fitote.2014.07.002_bb0290","first-page":"1181","article-title":"Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells","volume":"11","author":"Stahlhut","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"11","key":"10.1016\/j.fitote.2014.07.002_bb0295","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1158\/0008-5472.CAN-09-4303","article-title":"The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature","volume":"70","author":"Li","year":"2010","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.fitote.2014.07.002_bb0300","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00262-008-0458-9","article-title":"The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-delta dependent manner","volume":"57","author":"Hampson","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.fitote.2014.07.002_bb0305","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/15200","article-title":"Natural adjuvants: endogenous activators of dendritic cells","volume":"5","author":"Gallucci","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.fitote.2014.07.002_bb0310","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri1372","article-title":"Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses","volume":"4","author":"Seong","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.fitote.2014.07.002_bb0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nrc2110","article-title":"Protein kinase C and other diacylglycerol effectors in cancer","volume":"7","author":"Griner","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.fitote.2014.07.002_bb0320","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/BJ20130220","article-title":"Protein kinase C pharmacology: refining the toolbox","volume":"452","author":"Wu-Zhang","year":"2013","journal-title":"Biochem J"},{"issue":"12","key":"10.1016\/j.fitote.2014.07.002_bb0325","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrd3871","article-title":"Protein kinase C, an elusive therapeutic target?","volume":"11","author":"Mochly-Rosen","year":"2012","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.fitote.2014.07.002_bb0330","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/anie.201308281","article-title":"Omnia praeclara rara. The quest for ingenol heats up","volume":"53","author":"Appendino","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"issue":"5","key":"10.1016\/j.fitote.2014.07.002_bb0335","first-page":"555","article-title":"Tumor promoting and skin irritant diterpene esters of Euphorbia virgata latex","volume":"28","author":"Upadhyay","year":"1981","journal-title":"Neoplasma"},{"issue":"1","key":"10.1016\/j.fitote.2014.07.002_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/carcin\/8.1.1","article-title":"Structure\/activity relationships of polyfunctional diterpenes of the ingenane type. I. Tumor-promoting activity of homologous, aliphatic 3-esters of ingenol and of delta 7,8-isoingenol-3-tetradecanoate","volume":"8","author":"Sorg","year":"1987","journal-title":"Carcinogenesis"},{"issue":"3\u20134","key":"10.1016\/j.fitote.2014.07.002_bb0345","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s004320050146","volume":"124","author":"Zayed","year":"1998","journal-title":"J Cancer Res Clin Oncol"},{"issue":"6","key":"10.1016\/j.fitote.2014.07.002_bb0350","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1021\/ar020124b","article-title":"Synthetic diacylglycerols (DAG) and DAG-lactones as activators of protein kinase C (PK-C)","volume":"36","author":"Marquez","year":"2003","journal-title":"Acc Chem Res"},{"issue":"20","key":"10.1016\/j.fitote.2014.07.002_bb0355","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1016\/j.bmcl.2013.08.038","article-title":"Syntheses, biological evaluation and SAR of ingenol mebutate analogues for treatment of actinic keratosis and non-melanoma skin cancer","volume":"23","author":"Liang","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"issue":"6148","key":"10.1016\/j.fitote.2014.07.002_bb0360","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1126\/science.1241606","article-title":"14-step synthesis of (+)-ingenol from (+)-3-carene","volume":"341","author":"J\u00f8rgensen","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.fitote.2014.07.002_bb0365","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1039\/c3np20094a","article-title":"Concepts and technologies for tracking bioactive compounds in natural product extracts: generation of libraries, and hyphenation of analytical processes with Bioassays","volume":"30","author":"Potterat","year":"2013","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.fitote.2014.07.002_bb0370","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1021\/jm801514w","article-title":"Novel chemical space exploration via natural products","volume":"52","author":"Rosen","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.fitote.2014.07.002_bb0375","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1039\/c3np20106f","article-title":"Natural product isolation\u2014how to get from biological material to pure compounds","volume":"30","author":"Bucar","year":"2013","journal-title":"Nat Prod Rep"},{"issue":"3","key":"10.1016\/j.fitote.2014.07.002_bb0380","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1211\/0022357001773931","article-title":"Pharmacognosy in the new millennium: lead finding and biotechnology","volume":"52","author":"Verpoorte","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0385","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10295-006-0115-2","article-title":"New drugs from marine microbes: the tide is turning","volume":"33","author":"Newman","year":"2006","journal-title":"J Ind Microbiol Biotechnol"},{"key":"10.1016\/j.fitote.2014.07.002_bb0390","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1021\/np040031y","article-title":"Marine natural products and related compounds in clinical and advanced preclinical trials","volume":"67","author":"Newman","year":"2004","journal-title":"J Nat Prod"}],"container-title":["Fitoterapia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X14001828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0367326X14001828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,10]],"date-time":"2022-04-10T19:28:06Z","timestamp":1649618886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0367326X14001828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":78,"alternative-id":["S0367326X14001828"],"URL":"https:\/\/doi.org\/10.1016\/j.fitote.2014.07.002","relation":{},"ISSN":["0367-326X"],"issn-type":[{"value":"0367-326X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The value of nature's natural product library for the discovery of New Chemical Entities: The discovery of ingenol mebutate","name":"articletitle","label":"Article Title"},{"value":"Fitoterapia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fitote.2014.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}